Could endothelial TGFβ signaling be a promising new target for liver disease?

Research output: Contribution to journalEditorialpeer-review

External organisations

  • a National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit, Institute of Immunology and Immunotherapy , University of Birmingham , Birmingham , UK.


Original languageEnglish
Pages (from-to)637-639
Number of pages3
JournalExpert review of gastroenterology & hepatology
Issue number7
Early online date30 May 2018
Publication statusE-pub ahead of print - 30 May 2018


  • Endothelium, Chronic liver disease, Fibrosis, Therapy, TGFβ